好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Pulmonary Involvement in Patients with Contactin-1 IgG Associated Autoimmune Nodopathy
Neuromuscular and Clinical Neurophysiology (EMG)
P4 - Poster Session 4 (5:00 PM-6:00 PM)
11-020

To describe a potential new non-neurologic manifestation of contactin-1 IgG associated autoimmune nodopathy (CNTN1 AN).

We report two cases of CNTN1 AN linked to inflammatory pulmonary disease. Airway epithelial cells exposed to allergens have been shown to release CNTN1-bearing exosomes, which activate dendritic cells and promote Th2/Th17 responses. Elevated CNTN1 levels have also been found in the serum and lung tissues of asthma patients compared to healthy controls.

Case series.

Case 1: A 63-year-old man was diagnosed with CNTN1 AN after presenting with a chronic sensory-predominant demyelinating polyradiculoneuropathy, neuropathic pain, dysautonomia, lambda monoclonal paraproteinemia, and lymphadenopathy, along with positive CNTN1 IgG. At the time of diagnosis, he developed acute respiratory failure due to obstructive airway disease. A CT chest showed ground-glass pulmonary opacities. He also had hypereosinophilia (absolute eosinophil count 1.31x10?/L, normal 0.03-0.48x10?/L) and elevated IgE levels (5530kU/L, normal ≤214kU/L), leading to a diagnosis of new-onset asthma.

Case 2: A 33-year-old man was diagnosed with CNTN1 AN and biopsy-proven membranous nephropathy after presenting with a chronic sensory-predominant demyelinating polyradiculoneuropathy, proteinuria, lymphadenopathy, and polyclonal gammopathy (IgM and IgG), with positive CNTN1 IgG. A CT chest revealed asymptomatic ground-glass and cystic pulmonary changes. Pulmonary function tests and eosinophil counts were normal, and IgE levels were not measured. A lung biopsy showed follicular bronchiolitis with chronic interstitial inflammation, leading to a diagnosis of interstitial pneumonitis.

Both patients had no prior history of pulmonary disease. Extensive investigations for chronic infections (e.g., HIV, HHV8), systemic autoimmune conditions, and lymphoproliferative disorders yielded negative results. Both were treated with steroids and rituximab, resulting in good clinical outcomes.

These cases highlight a potential link between CNTN1 autoimmunity and pulmonary involvement. Further research, including additional cases, is needed to confirm this association and clarify the role of CNTN1 IgG in inflammatory lung disease.

Authors/Disclosures
Felipe Jones, MD
PRESENTER
Dr. Jones has nothing to disclose.
Naveen K. Paramasivan, MD (Flat B2, AKB SPRINGS) Dr. Paramasivan has nothing to disclose.
Marcus Vinicius R. Pinto, MD (Mayo Clinic) Dr. Pinto has nothing to disclose.
Divyanshu Dubey, MD, FAAN (Mayo Clinic) The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.